Cargando…
Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni
BACKGROUND: Schistosomiasis, one of the world’s greatest neglected tropical diseases, is responsible for over 280,000 human deaths per annum. Praziquantel, developed in the 1970s, has high efficacy, excellent tolerability, few and transient side effects, simple administration procedures and competit...
Autores principales: | Lalli, Cristiana, Guidi, Alessandra, Gennari, Nadia, Altamura, Sergio, Bresciani, Alberto, Ruberti, Giovina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312041/ https://www.ncbi.nlm.nih.gov/pubmed/25635836 http://dx.doi.org/10.1371/journal.pntd.0003484 |
Ejemplares similares
-
Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production
por: Guidi, Alessandra, et al.
Publicado: (2017) -
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production
por: Guidi, Alessandra, et al.
Publicado: (2018) -
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
por: Guidi, Alessandra, et al.
Publicado: (2016) -
Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by (1)H-NMR spectroscopy
por: Guidi, Alessandra, et al.
Publicado: (2020) -
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2022)